Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 February 2025 | Story Onthatile Tikoe | Photo Supplied
Shimlas 2024
The UFS Shimlas lifting the Varsity Cup on their home ground in Bloemfontein after their 2024 victory.

The highly anticipated Varsity Cup is finally here, and the University of the Free State (UFS) is buzzing with excitement! The tournament, which features the top university rugby teams in South Africa, promises to deliver thrilling matches and intense rivalries throughout the rugby season.

After an exhilarating 2024 season, the UFS Shimlas made history by lifting the Varsity Cup trophy on their home ground in Bloemfontein. The team’s impressive performance and dedication earned them a spot in the record books, and they are eager to repeat their success in 2025.

This year’s competition is scheduled to kick off on 17 February 2025 and will run for 7 weeks, with the UFS final game on 31 March 2025. The UFS Shimlas will be looking to defend their title and bring home the coveted trophy once again.

Previous winners

The Varsity Cup has a rich history, with previous winners including:

UFS Shimlas (2015, 2024)
Maties (Stellenbosch University, 2008-2010, 2019)
Tuks (University of Pretoria, 2012, 2013, 2017, 2021, 2022)
UCT Ikey Tigers (2011, 2014)

FNB NWU (2016, 2023)

UFS ready to take on the best

The UFS Shimlas have been preparing tirelessly for the tournament, with a strong focus on teamwork, discipline, and strategy. Head Coach André Tredoux expressed his excitement about the team’s prospects: “Being the defending champions comes with a bit of pressure, but we don’t see it that way. Our motto is that we want to attack the Varsity Cup, hence the best form of defence is to attack. The boys are really excited. They played well against UJ and scored lots of tries, hence our mindset is to attack everything we put our minds to.”

UFS Shimlas Team Captain Nkoka Ngobe echoed his coach’s sentiments, reinforcing his dedication to leading the team to victory. “As the team captain, I have to lead by example and bring the culture of excellence. I will never ask my teammates to do something that I cannot do, so the important thing for me is doing what it takes so that the boys can do the same.”

Get ready for the action

The Varsity Cup promises to deliver seven weeks of non-stop rugby action, with the UFS Shimlas ready to take on the best university teams in the country. Don’t miss out on the excitement – follow the UFS Shimlas on social media to stay up to date and get ready to cheer them on to victory!

Let’s go, Shimlas!

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept